(Date:11/24/2009)...ry efficacy endpoint has been met for patients wit...er, , QUEBEC CITY, Nov. 24 /PRNewswire-FirstC... AEZ) (the "Company"), a global biopharmaceutical ... today announced positive efficacy data from a Pha...jugate, AEZS-108 (formerly AN-152), in patients wi...
(Date:11/24/2009)...GO, Nov. 24, 2009 Arena ... today that the company is scheduled to present at...nce on December 1, 2009 at 11:30 a.m. Eastern Time...otel in New York City. Jack Lief, Arena,s Presiden...vide an overview of the company, including its cli...
(Date:11/24/2009)... Program Connects Customers with Partners Valida...DNA Genotek Products , Ot... , a leading provider of products for biological s...oday announced its new global partner program. The...enotek,s partner community and is designed to help...
(Date:11/23/2009)... 23, 2009 In a provocative new study, a Universit...ide emissions the major cause of global warming ...llapses or society builds the equivalent of one ne...ikely that there will be any substantial near-term...carbon dioxide emission rates," says the new paper...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4...NORCROSS, Ga., Oct. 26 Immucor, Inc.,(Nasdaq/NM: ...eagent,systems to the blood transfusion industry, ...any received a letter from the Federal Trade Commi...ily provide certain documents,and information to t...or in,the period from 1996 through 1999, and conce...
...SOUTH SAN FRANCISCO, Calif., Oct. 26 Sunesis,Phar...ge biopharmaceutical,company developing novel anti...nt will hold an investor conference call on Thursd...to discuss financial results for the,third quarter... access the call via (888),297-0358 (U.S. and Cana...
...EMERYVILLE, Calif., Oct. 25 NovaBay,Pharmaceutica...ing of its,initial public offering of 5,000,000 sh...of U.S. $4.00 per share. NovaBay has granted to th...n additional 750,000 shares,at the initial public ...he,shares will commence trading on October 26, 200...
Other Biology Technology:NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock 2NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock 3...e reagents for the isolation of genomic DNA. DNAzo...olation of genomic DNA from blood. Plant DNAzol Re... of genomic DNA from plants. Genomic DNA isolated ...ndonuclease digestion Southern blot analysis molec...
Death Check I Assay System (TUNEL/Caspase) from Promega
Plastic feeding tubes, 20ga x 38mm, sterile from Instech Solomon
DAPI/Antifade Solution from CHEMICON
Biology Products: